ATE483710T1 - Isochinolin-3-carbonsäureamide und ihre pharmazeutische verwendung - Google Patents

Isochinolin-3-carbonsäureamide und ihre pharmazeutische verwendung

Info

Publication number: ATE483710T1
Authority: AT; Austria
Prior art keywords: acid amides; isoquinoline; carbonic acid; pharmaceutical use; pharmaceuticals
Prior art date: 2003-05-12

Application number

AT04732091T

Other languages

English (en)

Inventor

Max Seiler

Original Assignee

Novartis Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-05-12

Filing date

2004-05-11

Publication date

2010-10-15

2004-05-11 Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh

2010-10-15 Application granted granted Critical

2010-10-15 Publication of ATE483710T1 publication Critical patent/ATE483710T1/de

Links

230000001270 agonistic effect Effects 0.000 abstract 1
102000047725 alpha7 Nicotinic Acetylcholine Receptor Human genes 0.000 abstract 1
108700006085 alpha7 Nicotinic Acetylcholine Receptor Proteins 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
KKSZSACCVDIWIE-UHFFFAOYSA-N isoquinoline-3-carboxamide Chemical class C1=CC=C2C=NC(C(=O)N)=CC2=C1 KKSZSACCVDIWIE-UHFFFAOYSA-N 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Psychology (AREA)
Rheumatology (AREA)
Hospice & Palliative Care (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT04732091T 2003-05-12 2004-05-11 Isochinolin-3-carbonsäureamide und ihre pharmazeutische verwendung ATE483710T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0310867.7A GB0310867D0 (en)	2003-05-12	2003-05-12	Organic compounds
PCT/EP2004/005042 WO2004099206A1 (en)	2003-05-12	2004-05-11	Isoquinoline-3-carboxylic acid amides and pharmaceutical uses thereof

Publications (1)

Publication Number	Publication Date
ATE483710T1 true ATE483710T1 (de)	2010-10-15

Family

ID=9957894

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04732091T ATE483710T1 (de)	2003-05-12	2004-05-11	Isochinolin-3-carbonsäureamide und ihre pharmazeutische verwendung

Country Status (12)

Country	Link
US (1)	US7683075B2 (de)
EP (1)	EP1633752B1 (de)
JP (1)	JP2006525976A (de)
CN (1)	CN100341874C (de)
AT (1)	ATE483710T1 (de)
AU (1)	AU2004235971C1 (de)
BR (1)	BRPI0410233A (de)
CA (1)	CA2524625A1 (de)
DE (1)	DE602004029462D1 (de)
GB (1)	GB0310867D0 (de)
MX (1)	MXPA05012154A (de)
WO (1)	WO2004099206A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR108325A1 (es) *	2016-04-27	2018-08-08	Samumed Llc	Isoquinolin-3-il carboxamidas y preparación y uso de las mismas
AR108326A1 (es)	2016-04-27	2018-08-08	Samumed Llc	Isoquinolin-3-il carboxamidas y preparación y uso de las mismas
TWI865563B (zh)	2019-07-30	2024-12-11	德商拜耳動物保健有限公司	新穎異喹啉衍生物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0311724A1 (de)	1987-10-16	1989-04-19	Synthelabo	Anxiolytische R-N-(1-Azabicyclo[2.2.2]oct-3-yl)-benzamide und -thiobenzamide
FR2625678B1 (fr)	1988-01-13	1991-06-07	Delalande Sa	Agents anorexigenes a base de n-(quinuclidin-3-yl)-benzamides ou thiobenzamides
EP0353372B1 (de)	1988-08-04	1993-02-03	Synthelabo	Antischizophren-wirksame S-N-(1-azabicyclo [2.2.2.]oct-3-yl)Benzamide und Thiobenzamide
EP0353371A1 (de)	1988-08-04	1990-02-07	Synthelabo	Steigerung der Gedächtnisleistung durch R-N-(1-azabicyclo[2.2.2]oct-3-yl)Benzamide und Thiobenzamide
GB9009542D0 (en)	1990-04-27	1990-06-20	Beecham Group Plc	Novel compounds
SE9600683D0 (sv)	1996-02-23	1996-02-23	Astra Ab	Azabicyclic esters of carbamic acids useful in therapy
SE0000540D0 (sv) *	2000-02-18	2000-02-18	Astrazeneca Ab	New compounds
PE20021019A1 (es) *	2001-04-19	2002-11-13	Upjohn Co	Grupos azabiciclicos sustituidos
AR036041A1 (es) *	2001-06-12	2004-08-04	Upjohn Co	Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen
BR0212477A (pt) *	2001-09-12	2004-08-24	Upjohn Co	7-aza[2.2.1] bicicloheptanos substituìdos para o tratamento de doenças
WO2003037896A1 (en) *	2001-10-26	2003-05-08	Pharmacia & Upjohn Company	N-azabicyclo-substituted hetero-bicyclic carboxamides as nachr agonists
EP1478646A1 (de) *	2002-02-20	2004-11-24	PHARMACIA & UPJOHN COMPANY	Azabicyclische verbindungen mit activität an alfa7 nikotinischen acetylcholin rezeptoren
EP1572300A1 (de)	2002-12-11	2005-09-14	Pharmacia & Upjohn Company LLC	Fixe kombination zur behandlung von adhd
MXPA05005666A (es)	2002-12-11	2005-07-26	Pharmacia & Upjohn Co Llc	Tratamiento de enfermedades con combinaciones de agonistas del receptor nicotinico de acetilcolina alfa-7 y otros compuestos.
JP2006515023A (ja) *	2003-01-22	2006-05-18	ファルマシア・アンド・アップジョン・カンパニー・エルエルシー	α−７ｎＡＣｈ受容体完全アゴニストによる疾患処置

2003
- 2003-05-12 GB GBGB0310867.7A patent/GB0310867D0/en not_active Ceased
2004
- 2004-05-11 EP EP04732091A patent/EP1633752B1/de not_active Expired - Lifetime
- 2004-05-11 MX MXPA05012154A patent/MXPA05012154A/es active IP Right Grant
- 2004-05-11 DE DE602004029462T patent/DE602004029462D1/de not_active Expired - Lifetime
- 2004-05-11 CA CA002524625A patent/CA2524625A1/en not_active Abandoned
- 2004-05-11 AT AT04732091T patent/ATE483710T1/de not_active IP Right Cessation
- 2004-05-11 CN CNB2004800124422A patent/CN100341874C/zh not_active Expired - Fee Related
- 2004-05-11 WO PCT/EP2004/005042 patent/WO2004099206A1/en not_active Ceased
- 2004-05-11 JP JP2006505416A patent/JP2006525976A/ja active Pending
- 2004-05-11 AU AU2004235971A patent/AU2004235971C1/en not_active Ceased
- 2004-05-11 US US10/556,356 patent/US7683075B2/en not_active Expired - Fee Related
- 2004-05-11 BR BRPI0410233-9A patent/BRPI0410233A/pt not_active IP Right Cessation

Also Published As

Publication number	Publication date
AU2004235971C1 (en)	2008-12-04
JP2006525976A (ja)	2006-11-16
AU2004235971B2 (en)	2008-04-03
CA2524625A1 (en)	2004-11-18
CN100341874C (zh)	2007-10-10
WO2004099206A1 (en)	2004-11-18
EP1633752B1 (de)	2010-10-06
EP1633752A1 (de)	2006-03-15
AU2004235971A1 (en)	2004-11-18
US7683075B2 (en)	2010-03-23
DE602004029462D1 (de)	2010-11-18
MXPA05012154A (es)	2006-02-08
GB0310867D0 (en)	2003-06-18
US20070142428A1 (en)	2007-06-21
BRPI0410233A (pt)	2006-05-09
CN1784404A (zh)	2006-06-07

Legal Events

Date	Code	Title	Description
2011-04-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
NO20051102L (no)	2005-05-04	Sulfonylamino-eddiksyre-derivater
NO20062677L (no)	2006-08-09	Benzyleteraminforbindelser anvendbare som CCR-5-antagonister
BR0315547A (pt)	2005-09-20	Derivados de quinolina como antagonistas de crth2
ATE461178T1 (de)	2010-04-15	Pyridazinyl-piperazine und deren verwendung als histamin-h3-rezeptorliganden
NO20070224L (no)	2007-04-02	2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
ATE435210T1 (de)	2009-07-15	Tetrahydroisochinolylacetamidderivate zur verwendung als orexinrezeptorantagonisten
ECSP055621A (es)	2005-04-18	Aza-biciclo-alquil-éteres y su uso como agonistas de alfa7-nachr
TW200732323A (en)	2007-09-01	Organic compounds
TW200505875A (en)	2005-02-16	Novel compounds
DK1499607T3 (da)	2006-04-18	4-(piperidyl- og pyrrolidyl-alkyl-ureido)-quinoliner som urotensin II-receptorantagonister
TW200508197A (en)	2005-03-01	Indolone-acetamide derivatives, processes for preparing them and their uses
GB0323204D0 (en)	2003-11-05	Organic compounds
MX2007007098A (es)	2007-06-22	Derivados de pirrol que tienen actividad antagonista del receptor crth2.
ATE383345T1 (de)	2008-01-15	Quinoxalin-3-on-verdindungen als orexin-rezeptor antagonisten.
DE60326263D1 (de)	2009-04-02	Pyrimidin-sulfonamide und ihre verwendung als endothelin-rezeptor-antagonisten
TW200745024A (en)	2007-12-16	Carboxamide derivatives as muscarinic receptor antagonists
EA200702375A1 (ru)	2008-06-30	Производные мочевины, способы их получения и применения
SE0300457D0 (sv)	2003-02-19	Novel compounds
ATE483710T1 (de)	2010-10-15	Isochinolin-3-carbonsäureamide und ihre pharmazeutische verwendung
DE602005019722D1 (de)	2010-04-15	Substituierte pyrrolidin-2-one
WO2007027742A3 (en)	2007-12-06	SMALL MOLECULE INTEGRIN α2βl/GPIa-IIa ANTAGONISTS
ATE524463T1 (de)	2011-09-15	4-chromenonyl-1,4-dihydropyridincarbonitrile und ihre verwendung
MXPA05005340A (es)	2005-11-17	Nuevos derivados antagonistas del receptor de la vitronectina, sus procedimientos de preparacion, su aplicacion como medicamentos y los compuestos farmaceuticos que los contienen.
MXPA05006587A (es)	2005-12-14	Compuestos de tiazol como derivados de antagonistas del receptor de la integrina.
DE602004025965D1 (en)	2010-04-22	Phosphinsäurederivate